×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
BMRA – biomerica, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BMRA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/17
08:19 am
bmra
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Disease Test for Early Detection of Kidney Damage
High
Report
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Disease Test for Early Detection of Kidney Damage
4/16
09:35 am
bmra
Biomerica Announces Reverse Stock Split [Yahoo! Finance]
Low
Report
Biomerica Announces Reverse Stock Split [Yahoo! Finance]
4/16
09:00 am
bmra
Biomerica Announces Reverse Stock Split
High
Report
Biomerica Announces Reverse Stock Split
4/15
09:05 am
bmra
Biomerica Reports Third Quarter Fiscal 2025 Financial Results [Yahoo! Finance]
Medium
Report
Biomerica Reports Third Quarter Fiscal 2025 Financial Results [Yahoo! Finance]
4/15
08:19 am
bmra
Biomerica Reports Third Quarter Fiscal 2025 Financial Results
Medium
Report
Biomerica Reports Third Quarter Fiscal 2025 Financial Results
2/26
08:19 am
bmra
Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis
Medium
Report
Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis
2/19
08:27 am
bmra
Biomerica's inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal [Yahoo! Finance]
Medium
Report
Biomerica's inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal [Yahoo! Finance]
2/19
08:19 am
bmra
Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal
Medium
Report
Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/16
09:00 am
bmra
Form 8-K BIOMERICA INC For: Apr 15
High
Report
Form 8-K BIOMERICA INC For: Apr 15
4/14
04:15 pm
bmra
Form 10-Q BIOMERICA INC For: Feb 28
Medium
Report
Form 10-Q BIOMERICA INC For: Feb 28
2/11
04:32 pm
bmra
Form SCHEDULE 13G BIOMERICA INC Filed by: WASATCH ADVISORS LP
Medium
Report
Form SCHEDULE 13G BIOMERICA INC Filed by: WASATCH ADVISORS LP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/17
Biomerica Begins Shipping Samples of 10 Minute Test for COVID-19 Virus Exposure
334.6%
3/22 Labs race to produce tests that show where COVID-19 has already been [Toronto Globe and Mail (Ontario, Canada)] 35.8%
10/15 Q1/2020 8/31/2019 EPS -0.050 ZacksConsensus -0.060 ActVsEst 0.010 - Beat 9.7%
6/5 Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million. 8.0%
3/4 Form SC 13D BIOMERICA INC Filed by: Palm Management (US) LLC 6.1%
9/11 Biomerica, Inc. (NASDAQ: BMRA) was given a new $6.00 price target on by analysts at B. Riley. They now have a "buy" rating on the stock. 6.1%
12/30 Biomerica, Inc. (NASDAQ: BMRA) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 5.4%
4/3 Form 4 BIOMERICA INC For: Apr 01 Filed by: BARBIERI ALLEN 3.0%
1/9 Form 8-K BIOMERICA INC For: Jan 09 2.8%
12/23 Form 4 BIOMERICA INC For: Dec 19 Filed by: BARBIERI ALLEN 2.7%
3/22 Labs race to produce tests that show where COVID-19 has already been [Toronto Globe and Mail (Ontario, Canada)] 35.8%
10/15 Q1/2020 8/31/2019 EPS -0.050 ZacksConsensus -0.060 ActVsEst 0.010 - Beat 9.7%
6/5 Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million. 8.0%
3/4 Form SC 13D BIOMERICA INC Filed by: Palm Management (US) LLC 6.1%
9/11 Biomerica, Inc. (NASDAQ: BMRA) was given a new $6.00 price target on by analysts at B. Riley. They now have a "buy" rating on the stock. 6.1%
12/30 Biomerica, Inc. (NASDAQ: BMRA) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 5.4%
4/3 Form 4 BIOMERICA INC For: Apr 01 Filed by: BARBIERI ALLEN 3.0%
1/9 Form 8-K BIOMERICA INC For: Jan 09 2.8%
12/23 Form 4 BIOMERICA INC For: Dec 19 Filed by: BARBIERI ALLEN 2.7%
TOP News Decliners
3/20
Form 424B5 BIOMERICA INC
-41.5%
6/5 Form 8-K BIOMERICA INC For: May 31 -8.8%
4/2 A coronavirus immunity test is essential for the U.S. But will it work? [Los Angeles Times (CA)] -7.6%
3/25 U.S. companies, labs rush to produce blood test for coronavirus immunity [Reuters] -7.3%
3/2 Form 4 BIOMERICA INC For: Feb 28 Filed by: Irani Zackary S. -5.8%
1/14 Form 10-Q BIOMERICA INC For: Nov 30 -5.4%
11/7 Biomerica, Inc. (NASDAQ: BMRA) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -4.5%
4/14 Form 10-Q BIOMERICA INC For: Feb 29 -3.8%
4/21 Form 4 BIOMERICA INC For: Apr 17 Filed by: Sirgo Mark A -3.0%
4/6 Form 8-K BIOMERICA INC For: Apr 01 -1.3%
6/5 Form 8-K BIOMERICA INC For: May 31 -8.8%
4/2 A coronavirus immunity test is essential for the U.S. But will it work? [Los Angeles Times (CA)] -7.6%
3/25 U.S. companies, labs rush to produce blood test for coronavirus immunity [Reuters] -7.3%
3/2 Form 4 BIOMERICA INC For: Feb 28 Filed by: Irani Zackary S. -5.8%
1/14 Form 10-Q BIOMERICA INC For: Nov 30 -5.4%
11/7 Biomerica, Inc. (NASDAQ: BMRA) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -4.5%
4/14 Form 10-Q BIOMERICA INC For: Feb 29 -3.8%
4/21 Form 4 BIOMERICA INC For: Apr 17 Filed by: Sirgo Mark A -3.0%
4/6 Form 8-K BIOMERICA INC For: Apr 01 -1.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: